{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:30:34Z","timestamp":1793136634969,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":75,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01-CX001901"],"award-info":[{"award-number":["I01-CX001901"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL148182"],"award-info":[{"award-number":["R01HL148182"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jocmr.2026.102719","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:59:58Z","timestamp":1773968398000},"page":"102719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety and T1 reactivity for vasodilator stress ferumoxytol-enhanced cardiac magnetic resonance imaging"],"prefix":"10.1016","volume":"28","author":[{"given":"Arutyun","family":"Pogosyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Keushkerian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyang","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung S.","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8854-2976","authenticated-orcid":false,"given":"Kim-Lien","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jocmr.2026.102719_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00059-003-2451-6","article-title":"Myocardial microcirculation in humans--new approaches using MRI","volume":"28","author":"Wacker","year":"2003","journal-title":"Herz"},{"issue":"1","key":"10.1016\/j.jocmr.2026.102719_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1532-429X-12-57","article-title":"Quantification of myocardial perfusion by cardiovascular magnetic resonance","volume":"12","author":"Jerosch-Herold","year":"2010","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"10.1016\/j.jocmr.2026.102719_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/10976640601187604","article-title":"Imaging sequences for first pass perfusion --a review","volume":"9","author":"Kellman","year":"2007","journal-title":"J Cardiovasc Magn Reson"},{"issue":"5","key":"10.1016\/j.jocmr.2026.102719_bib4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/mrm.20666","article-title":"On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies","volume":"54","author":"Di Bella","year":"2005","journal-title":"Magn Reson Med"},{"issue":"2","key":"10.1016\/j.jocmr.2026.102719_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocmr.2025.101900","article-title":"Advanced cardiac magnetic resonance imaging for assessment of obstructive coronary artery disease-ADVOCATE-CMR study rationale and design","volume":"27","author":"Borodzicz-Jazdzyk","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"10.1016\/j.jocmr.2026.102719_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocmr.2025.101991","article-title":"Corrigendum to \"Society for Cardiovascular Magnetic Resonance recommendations toward environmentally sustainable cardiovascular magnetic resonance\" [Journal of Cardiovascular Magnetic Resonance 27 (2025) 101840","volume":"27","author":"Hanneman","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"issue":"7","key":"10.1016\/j.jocmr.2026.102719_bib7","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s10554-019-01554-4","article-title":"T1 reactivity as an imaging biomarker in myocardial tissue characterization discriminating normal, ischemic and infarcted myocardium","volume":"35","author":"van Assen","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.jocmr.2026.102719_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10334-017-0649-5","article-title":"State-of-the-art review: stress T1 mapping-technical considerations, pitfalls and emerging clinical applications","volume":"31","author":"Piechnik","year":"2018","journal-title":"MAGMA"},{"issue":"6","key":"10.1016\/j.jocmr.2026.102719_bib9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/ehjci\/jeaf059","article-title":"Stress T1 mapping and quantitative perfusion cardiovascular magnetic resonance in patients with suspected obstructive coronary artery disease","volume":"26","author":"Borodzicz-Jazdzyk","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.jocmr.2026.102719_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4518","article-title":"Ferumoxytol-enhanced magnetic resonance T1 reactivity for depiction of myocardial hypoperfusion","volume":"34","author":"Colbert","year":"2021","journal-title":"NMR Biomed"},{"issue":"8 Pt 1","key":"10.1016\/j.jocmr.2026.102719_bib11","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jcmg.2019.01.024","article-title":"Ferumoxytol-enhanced CMR for vasodilator stress testing: a feasibility study","volume":"12","author":"Nguyen","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.jocmr.2026.102719_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/RLI.0000000000000434","article-title":"Relaxivity of ferumoxytol at 1.5 T and 3.0 T","volume":"53","author":"Knobloch","year":"2018","journal-title":"Invest Radio"},{"issue":"4","key":"10.1016\/j.jocmr.2026.102719_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000087212","article-title":"Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients","volume":"25","author":"Landry","year":"2005","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.jocmr.2026.102719_bib14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2214\/AJR.22.28453","article-title":"Ferumoxytol-enhanced MRI in children and young adults: state of the art","volume":"220","author":"Adams","year":"2023","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.jocmr.2026.102719_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajh.21656","article-title":"FDA report: ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease","volume":"85","author":"Lu","year":"2010","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.jocmr.2026.102719_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mrm.20110","article-title":"Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart","volume":"52","author":"Messroghli","year":"2004","journal-title":"Magn Reson Med"},{"issue":"3","key":"10.1016\/j.jocmr.2026.102719_bib17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12350-015-0387-x","article-title":"ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers","volume":"23","author":"Henzlova","year":"2016","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"10.1016\/j.jocmr.2026.102719_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00247-016-3762-0","article-title":"Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson","volume":"47","author":"Noel","year":"2017","journal-title":"Pedia Radio"},{"key":"10.1016\/j.jocmr.2026.102719_bib19","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE): U.S. Department of Health and Human Services, National Institutes of Health; 2017 [08\/31\/2023]. Version 5.0: [Available from: \u3008https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm\u3009."},{"issue":"2","key":"10.1016\/j.jocmr.2026.102719_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.jocmr.2026.102719_bib21","doi-asserted-by":"crossref","DOI":"10.25080\/Majora-92bf1922-011","article-title":"Statsmodels: econometric and statistical modeling with python","volume":"7","author":"Seabold","year":"2010","journal-title":"SciPy"},{"issue":"2","key":"10.1016\/j.jocmr.2026.102719_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/jdi.12401","article-title":"Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors","volume":"7","author":"Ogawa","year":"2016","journal-title":"J Diabetes Invest"},{"issue":"8","key":"10.1016\/j.jocmr.2026.102719_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/anae.14251","article-title":"Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations","volume":"73","author":"Milder","year":"2018","journal-title":"Anaesthesia"},{"issue":"6","key":"10.1016\/j.jocmr.2026.102719_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4158\/EP161292.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of Sglt-2 Inhibitors and Diabetic Ketoacidosis","volume":"22","author":"Handelsman","year":"2016","journal-title":"Endocr Pr"},{"issue":"2","key":"10.1016\/j.jocmr.2026.102719_bib25","first-page":"137","article-title":"Prevention and management of acute reactions to intravenous iron in surgical patients","volume":"17","author":"Gomez-Ramirez","year":"2019","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jocmr.2026.102719_bib26","first-page":"S107","article-title":"Labile iron: manifestations and clinical implications","volume":"15 2","author":"Van Wyck","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jocmr.2026.102719_bib27","unstructured":"Feraheme [prescribing information]. AMAG Pharmaceuticals, Inc., February 2018."},{"issue":"2","key":"10.1016\/j.jocmr.2026.102719_bib28","doi-asserted-by":"crossref","first-page":"101980","DOI":"10.1016\/j.jocmr.2025.101980","article-title":"Ferumoxytol-enhanced cardiovascular magnetic resonance imaging: applications and technical advances","volume":"27","author":"Nguyen","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"issue":"13","key":"10.1016\/j.jocmr.2026.102719_bib29","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1007\/s00247-023-05778-4","article-title":"Brand ferumoxytol vs. generic ferumoxytol comparison across two dosing regimens: a cardiac MRI image quality study","volume":"53","author":"Dasi","year":"2023","journal-title":"Pediatr Radiol"},{"issue":"3","key":"10.1016\/j.jocmr.2026.102719_bib30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/jmri.25412","article-title":"MRI with ferumoxytol:\u00a0a\u00a0single center experience of safety across the age spectrum","volume":"45","author":"Nguyen","year":"2017","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.jocmr.2026.102719_bib31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1148\/radiol.2019190477","article-title":"Multicenter safety and practice for off-label diagnostic use of ferumoxytol in MRI","volume":"293","author":"Nguyen","year":"2019","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jocmr.2026.102719_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/RLI.0000000000000230","article-title":"Safety report of ferumoxytol for magnetic resonance imaging in children and young adults","volume":"51","author":"Muehe","year":"2016","journal-title":"Invest Radiol"},{"issue":"26","key":"10.1016\/j.jocmr.2026.102719_bib33","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/eurheartj\/ehv626","article-title":"Coronary pressure and flow relationships in humans: phasic analysis of normal and pathological vessels and the implications for stenosis assessment: a report from the Iberian-Dutch-English (IDEAL) collaborators","volume":"37","author":"Nijjer","year":"2016","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.jocmr.2026.102719_bib34","first-page":"833","article-title":"Precision of myocardial T1- and T2-mapping using CMR","volume":"17","author":"Meier","year":"2024","journal-title":"Prospect ScanRescan Approach Assess Mapp Data Reprod JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.jocmr.2026.102719_bib35","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/jmri.24691","article-title":"Emerging applications for ferumoxytol as a contrast agent in MRI","volume":"41","author":"Bashir","year":"2015","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.jocmr.2026.102719_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7150\/ntno.46356","article-title":"Brain iron deposition after Ferumoxytol-enhanced MRI: a\u00a0study of Porcine Brains","volume":"4","author":"Theruvath","year":"2020","journal-title":"Nanotheranostics"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664726000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664726000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T13:23:57Z","timestamp":1781097837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097664726000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1097664726000372"],"URL":"https:\/\/doi.org\/10.1016\/j.jocmr.2026.102719","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and T1 reactivity for vasodilator stress ferumoxytol-enhanced cardiac magnetic resonance imaging","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocmr.2026.102719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Society for Cardiovascular Magnetic Resonance.","name":"copyright","label":"Copyright"}],"article-number":"102719"}}